# Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.

> **NCT06914557** · PHASE2 · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Pain

## Interventions

- **DEVICE:** Scrambler Therapy
- **OTHER:** Questionnaire and Physical Exam

## Key facts

- **NCT ID:** NCT06914557
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914557, "Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06914557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*